[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523152":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":41,"responsibleParty":56,"collaborators":26,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":26,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":26,"enrollmentInfo":67,"targetDuration":26,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":26,"overallStatus":43,"whyStopped":26,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"sufentanil group","EXPERIMENTAL","sufentanil is administered for analgesic during general anesthesia",[13],"Drug: Sufentanil",{"label":15,"type":16,"description":17,"interventionNames":18},"remifentanil group","ACTIVE_COMPARATOR","remifentanil is administered for analgesic during general anesthesia",[19],"Drug: Remifentanil",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Sufentanil","Induction: sufentanil TCI 0.3 ng\u002Fml Maintenance: sufentanil TCI 0.05-0.5 ng\u002Fml",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Remifentanil","Induction: remifentanil TCI 3 ng\u002Fml Maintenance: remifentanil TCI 0.5-5 ng\u002Fml",[15],[32],{"name":33,"affiliation":34,"role":35},"Chang-Hoon Koo","Seoul National University Bundang Hospital","PRINCIPAL_INVESTIGATOR",[37],{"name":33,"role":38,"phone":39,"phoneExt":26,"email":40},"CONTACT","+821085098841","vollock9@gmail.com",[42],{"facility":34,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":26,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Seongnam-si","Gyeonggi-do","13620","South Korea",{"type":49,"coordinates":50},"Point",[51,52],127.13778,37.43861,{"lat":52,"lon":51},[55],{"name":33,"role":38,"phone":26,"phoneExt":26,"email":40},{"type":35,"investigatorFullName":33,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Assistant professor","100523152","effects-of-sufentanil-on-the-intraoperative-hemodynamics-100523152",false,"NCT06091904","Effects of Sufentanil on the Intraoperative Hemodynamics","Effects of Sufentanil on the Intraoperative Hemodynamic Parameters in Patients Undergoing Extracranial-intracranial Bypass Surgery: a Prospective Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients who undergo elective extracranial-intracranial bypass surgery\n* American Society of Anesthesiologists grade 1,2,3\n* Age \\> 18 years old\n\nExclusion Criteria:\n\n* Refuse to participate to the study\n* American Society of Anesthesiologists grade 4\n* Body Mass Index \\\u003C 18.5 kg\u002Fm2 or \\> 35 kg\u002Fm2\n* Allergic history of opioid\n* pregnant\n* MAO Inhibitor user\n* Severe respiratory insufficiency","ALL","19 Years",{"count":68,"type":69},92,"ESTIMATED","INTERVENTIONAL",[72],"NA","This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.",[75],"Intraoperative Hypotension","2025-09-10",{"date":78,"type":79},"2025-09-16","ACTUAL",{"date":81,"type":79},"2023-11-24",{"date":83,"type":69},"2026-11-01",{"name":5,"class":6},1]